4//SEC Filing
Fishel Robert Scott 4
Accession 0001209191-21-005357
CIK 0000944809other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:07 PM ET
Size
11.7 KB
Accession
0001209191-21-005357
Insider Transaction Report
Form 4
Fishel Robert Scott
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-25$2.03/sh+20,000$40,600→ 60,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-25−40,000→ 0 totalExercise: $3.04From: 2019-04-03Exp: 2028-04-02→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2021-01-25$3.04/sh+40,000$121,600→ 40,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-25−20,000→ 0 totalExercise: $2.03From: 2020-06-20Exp: 2029-06-19→ Common Stock (20,000 underlying)
Holdings
- 4,120,728(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation.
Documents
Issuer
OPKO HEALTH, INC.
CIK 0000944809
Entity typeother
Related Parties
1- filerCIK 0001735476
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:07 PM ET
- Size
- 11.7 KB